Analysts think APTOF stock price could increase by 4809%
May 08, 2025, 11:26 AM
-12.00%
What does APTOF do
Aptose Biosciences, headquartered in North York, Ontario, specializes in developing precision anti-cancer therapies, focusing on hematology with two clinical-stage oral kinase inhibitors for hematologic malignancies. The company employs 35 staff and aims to address unmet clinical needs.
5 analysts think APTOF stock price will increase by 4808.75%. The current median analyst target is $98.17 compared to a current stock price of $2.00. The lowest analysts target is $12.63 and the highest analyst target is $189.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.